Our previous work indicated that CRC cell lines expressing wild-type p53 were not more sensitive to aspirin-induced apoptosis mediated by NFκB signalling, but there are differences other than p53 status between the cell lines studied (Din et al, 2004). The gene discussed is TP53; the disease is colorectal carcinoma.